XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Compare which index fund is best after rolling over an IRA by examining expense ratios, tracking error, and portfolio breadth to support retirement goals.
27,882 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
New data reveals JNK’s 0.40% expense ratio quietly drains returns, especially for long-term holders, even when junk-b...
Stocks have held up, but the bond market is sending a warning. This article breaks down what the bond market sounding...
Matrixport’s fear index shows mounting pessimism as Bitcoin whipsaws in a volatile market. While downside risk remain...
When a legendary investor hands the reins, the next era often comes with bolder bets. This article examines berkshire...
A niche nuclear tech stock reported solid revenue gains, but a large fund reduced its holdings. Learn how to read the...
March has delivered a mixed bag for investors as oil swings, AI news, and private credit worries collide. This guide ...
In 2026, four Dividend Kings are outperforming the S&P 500 as investors pivot to cash-flow creators. The move signals...
Bitcoin edged above $65,000 as oil prices slipped, but traders warn that stubborn dollar strength and elevated yields...
Bitcoin prices retreat toward $60,000 while the Fear & Greed Index hits Extreme Fear. Here’s how traders assess risk,...
SpaceX is lining up what could be the largest IPO in U.S. history, targeting about $75 billion by selling hundreds of...
This article breaks down Alliant Energy's 2025 earnings outlook, capital plan, and dividend strategy. Learn what to w...